A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

While every person's journey with PF is unique, columnist Sam Kirton stresses the importance of support groups for patients and caregivers.

Weight loss is a recurring topic during my medical appointments, and I frequently discuss it with my transplant team. I wrote about this a couple years ago in a column titled “Using Ozempic in hopes ...

It was five years ago this month that COVID-19 was beginning to consume the headlines. Around the world, those headlines provided an early view of what a pandemic might look like here in the U.S. In ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Columnist Sam Kirton and his wife go with the flow when changes are necessary, such as rescheduling a Halloween party to the advent of spring.

Enrollment is now complete in a Phase 2b clinical trial, dubbed CORAL, that’s testing nalbuphine extended-release (ER) tablets — planned to be marketed as Haduvio — in people with idiopathic pulmonary ...

Do you ever have one of those days? You know the kind: Nothing seems to go your way and the day ends with a huge sigh. When I was diagnosed with idiopathic pulmonary fibrosis, I learned that not every ...